Back to search

Article

Identification of Germline Cancer Predisposition Variants During Clinical Ctdna Testing

2021-03-02

Abstract excerpt

Next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) is a non-invasive method to guide therapy selection for cancer patients. ctDNA variant allele frequency (VAF) is commonly reported and may aid in discerning whether a variant is germline or somatic. We report on the fidelity of VAF in ctDNA as a predictor for germline variant carriage. Two patient cohorts were studied. Cohort 1 included patients wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7b12d520-3603-593c-b7b7-5c6df0506ad3
DOI
10.21203/rs.3.rs-256641/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of Germline Cancer Predisposition Variants During Clinical Ctdna TestingDOI 10.21203/rs.3.rs-256641/v1
Select a neighboring publication to make it the new centre.